IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tang Capital Management LLC

Q2 2016 Holdings

Filed 2016-08-15 | 13 holdings | $13.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$7.0M90,21553.1%
Alibaba Group Holding Limited(BABA)SPONSORED ADS01609W102$4.8M60,00036.1%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$1.2M430,0009.2%
Heron Therapeutics Inc(HRTX)COM427746102$111.9K6,197,1980.8%
LA Jolla Pharmaceutical Co(LJPC)COM503459604$48.8K3,052,1300.4%
Ignyta IncCOM451731103$21.5K3,972,8000.2%
Opko Health IncDEBT 3.0% 2/1/3368375NAB9$19.8K$14,000,0000.1%
Merrimack Pharmaceuticals IncNOTE 4.5% 7/15/20590328AA8$4.0K$3,500,0000.0%
Nektar Therapeutics(NKTREUR)COM640268108$3.7K260,0000.0%
Lipocine IncCOM53630X104$790260,0000.0%
Atyr Pharma Inc(LIFEUSD)COM002120103$777279,4250.0%
Celldex Therapuetics IncCOM15117B103$22050,0000.0%